MedPath

津药和平(天津)制药有限公司

Ownership
-
Established
2010-11-12
Employees
-
Market Cap
-
Website
http://www.kingyork.biz/html/5

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

231

NMPA:231

Drug Approvals

Hydrocortisone Sodium Succinate for Injection

Product Name
注射用氢化可的松琥珀酸钠
Approval Number
国药准字H20253862
Approval Date
Apr 15, 2025
NMPA

Hydrocortisone Sodium Succinate for Injection

Product Name
注射用氢化可的松琥珀酸钠
Approval Number
国药准字H20253863
Approval Date
Apr 15, 2025
NMPA

Formoterol Fumarate Inhalation Solution

Product Name
富马酸福莫特罗吸入溶液
Approval Number
国药准字H20253219
Approval Date
Jan 14, 2025
NMPA

Betamethasone Sodium Phosphate Injection

Product Name
倍他米松磷酸钠注射液
Approval Number
国药准字H20249438
Approval Date
Nov 22, 2024
NMPA

Diprophylline Injection

Product Name
二羟丙茶碱注射液
Approval Number
国药准字H20247269
Approval Date
Nov 4, 2024
NMPA

Methylprednisolone Sodium Succinate for Injection

Product Name
注射用甲泼尼龙琥珀酸钠
Approval Number
国药准字H20247165
Approval Date
Jul 15, 2024
NMPA

Compound Ipratropium Bromide Solution for Inhalation

Product Name
吸入用复方异丙托溴铵溶液
Approval Number
国药准字H20243493
Approval Date
Apr 17, 2024
NMPA

Acetylcysteine Solution for Inhalation

Product Name
吸入用乙酰半胱氨酸溶液
Approval Number
国药准字H20243468
Approval Date
Apr 11, 2024
NMPA

Travoprost Eye Drops

Product Name
曲伏前列素滴眼液
Approval Number
国药准字H20234412
Approval Date
Oct 27, 2023
NMPA

Magnesium Sulfate Injection

Product Name
硫酸镁注射液
Approval Number
国药准字H20237128
Approval Date
Oct 24, 2023
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 24
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.